Clinical Trial Update: Aspirin and Enoxaparin for VTE in Trauma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating aspirin and enoxaparin for venous thromboembolism prevention in trauma patients has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboprophylaxis
• Trauma
• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Miami | Conditions: Venous Thromboembolism, Thromboprophylaxis | Phase 4 | Status: TERMINATED | Results posted: 2019-11-19